|
Mechanismgp140 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
在HIV阴性的健康志愿者中评价不同间隔复种rTV疫苗的安全性与免疫原性的IIa期临床试验
[Translation] A phase IIa clinical trial to evaluate the safety and immunogenicity of rTV vaccine at different intervals in HIV-negative healthy volunteers
主要观察DNA疫苗接种三次后,两次rTV疫苗不同时间间隔接种的安全性和免疫原性,对比观察不同间隔复种rTV疫苗对免疫原性的影响,确定最佳免疫应答的免疫接种程序。
[Translation] The safety and immunogenicity of two rTV vaccine vaccinations at different time intervals were mainly observed after three DNA vaccinations.
在健康志愿者中评价复种重组痘苗病毒(rTV)艾滋病疫苗的安全性与免疫原性的Ic期扩大临床试验
[Translation] A Phase Ic Expanded Clinical Trial to Evaluate the Safety and Immunogenicity of a Re-vaccinated Recombinant Vaccinia Virus (rTV) AIDS Vaccine in Healthy Volunteers
观察复种rTV疫苗在健康志愿者中的安全性,以及rTV疫苗复种对HIV特异性免疫反应的加强作用及其持久性。
[Translation] To observe the safety of revaccination rTV vaccine in healthy volunteers, as well as the strengthening effect and persistence of rTV vaccine revaccination on HIV-specific immune response.
在健康志愿者中评价复种重组痘苗病毒(rTV)艾滋病疫苗的安全性与免疫原性的Ic期临床试验
[Translation] A Phase Ic clinical trial evaluating the safety and immunogenicity of a revaccinated recombinant vaccinia virus (rTV) AIDS vaccine in healthy volunteers
观察复种rTV疫苗在健康志愿者中的安全性和耐受性,以及rTV疫苗复种对HIV特异性免疫反应的加强作用及其持久性。
[Translation] To observe the safety and tolerability of revaccination rTV vaccine in healthy volunteers, as well as the strengthening effect and persistence of rTV vaccine revaccination on HIV-specific immune response.
100 Clinical Results associated with Chinese Center For Aids/Std Control And Prevention, China Cdc
0 Patents (Medical) associated with Chinese Center For Aids/Std Control And Prevention, China Cdc
100 Deals associated with Chinese Center For Aids/Std Control And Prevention, China Cdc
100 Translational Medicine associated with Chinese Center For Aids/Std Control And Prevention, China Cdc